How to Choose the Best Partner for Your Biologic Development and Manufacturing

Custom content for Catalent Biologics by BioPharma Dive's Brand Studio

WEBINAR ON-DEMAND
Duration: 1 hour


Biologic development is complex, requiring a significant amount of time and resources to ensure the best chance of success. Consequently, there are numerous aspects to consider when evaluating prospective partners to take on all – or some – of your biologic development and manufacturing.

While some factors are easy to discern, others are more complex. You need to consider your preferred collaboration and communication styles, your potential partners’ track records, your expectations of working with them, as well as the long-term needs of your molecule and future molecules.

Our new webinar will provide guidance on the ins and outs of working with external partners, also known as contract development and manufacturing organizations, or CDMOs, to develop biologics. The webinar will also address:

  • The importance of keeping the future in mind when selecting a CDMO partner
  • Questions to ask when choosing a partner
  • The results from a recent Catalent Biologics/BioPharma Dive Brand Studio survey that assessed what today’s industry professionals consider most important when they are developing a new therapy

SPEAKERS  

Steven Hager, PhD
Senior Director, Technical Sales Support, Catalent Biologics


Deepak Verma
Founder,
ConsultPharma LLC


Catherine Dold
Contributing Writer,
BioPharma Dive’s Brand Studio

WATCH NOW

Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor
Field will not be visible to web visitor

Copyright 2019 Industry Dive